about
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociApoptosis, Necrosis, and Necroptosis in the Gut and Intestinal HomeostasisThe Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinaseIncidence in pediatric IBD is rising: help from health administrative data.A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease.Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in MiceMacrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseasePediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?Advances in the medical management of paediatric IBD.Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.Use of chromosome painting for detecting stable chromosome aberrations induced by melphalan in mice.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells.NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation.Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation.Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients.Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity.Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.Krill oil reduces intestinal inflammation by improving epithelial integrity and impairing adherent-invasive Escherichia coli pathogenicity.Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.Cytogenetic biomonitoring carried out in a village (Dolon) adjacent to the Semipalatinsk nuclear weapon test site.Lactobacillus reuteri ATCC55730 in cystic fibrosis.Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease.Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.RETRACTED: Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.935 MHz cellular phone radiation. An in vitro study of genotoxicity in human lymphocytes.Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease.Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver diseasePaediatric ulcerative colitis—can we predict proctocolectomy?Usefulness of single-balloon enteroscopy in pediatric Crohn's diseaseFecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease
P50
Q24618592-868EAAE9-670F-4B4F-9DFB-7496A69C4540Q26781665-AF5E861C-DACC-4974-8CFB-CF477CE183C5Q27704686-58B66584-1BC9-4FF6-AC0E-272DCD207057Q33842495-AF3E593B-0794-4FC0-9679-A5038E2D6ACAQ33857689-54300156-4034-44AD-B77E-FE204EB4B6B9Q34698326-C73F8F5A-036E-4D39-B901-6105DDB7CE78Q34805688-89D545C8-8178-4D43-8619-1171C68173C4Q36054281-47AC9685-A648-4EAD-BAE9-C0ABACA62EA3Q36561514-2D277774-202C-4758-8F55-FEC7BE7B05FEQ37411004-9835912E-94AF-4343-B168-D037C8A4458FQ38130044-10892053-0C39-445D-A662-82CB254D4590Q38456436-18512951-2643-4AE2-B985-05C2E031D757Q38475349-79EB2E09-D891-41A1-B37E-6422E2E54189Q38665591-76E94B53-1E71-48B1-972A-734C4B2AACA6Q38762721-9C9B8114-060F-4C0A-8C3D-D7734ED04086Q38804870-C58E541D-691D-4863-899E-7102ABF7B55CQ38845372-4EA5D9AC-4E3A-4A76-9D6D-1906DD62B449Q39045044-22CC2785-AE73-42D3-B8C4-A2FB1F077653Q39459047-4D723BE1-83A8-4BBA-A94C-AC3DC52FAD14Q39589053-26FFC8E5-0DCC-4EDF-9588-913381770723Q39995349-B1113D1F-C75A-4057-B69C-F6EE55EF2A61Q40706893-A1AE7D7B-969C-4741-88A6-DF2B65A9BA7BQ40940507-FB2F3540-6C5C-4297-B0BE-BBFCF3A1847DQ43069254-B174B416-776A-4518-94B5-24B90AEBCF45Q46097846-896990DA-26AB-406C-96A9-D34298F83139Q47280430-BAF3FFC7-9F71-4E5D-8991-6153698DD96AQ47888598-9C7325E0-B4CD-4D10-805F-B5F58BA55075Q50764442-749F493D-8C2B-46D5-AB70-35CB7D6B2F37Q50804121-5CCDB759-F0B7-45A3-934A-55D241149164Q51479359-D670E728-C931-4498-9450-C536844ECDBEQ52629486-B2703867-E1B3-4771-A289-31079CF7CA36Q52878053-FA00A443-052E-4B86-BE5D-0BF9F2BDAB85Q53617255-0330B69A-6E9B-4E7B-96CA-CE372BB8E8ABQ54200175-556544C6-4ABF-4D40-8A82-789DC9C1EC54Q54293140-31B993AF-BD12-46DD-A8D9-A5B808ACD079Q54491760-A306ADB4-CFE3-43DC-987B-0B8E9E3CF349Q57803934-66C44607-EB4E-40AF-9EC6-604FE734CCFCQ57804084-AF6F0169-87AE-4390-AF08-60AC1E426FB9Q57804089-52326C97-FDC7-41BB-BBA9-F0593A6346D3Q57804107-E293C4AE-AB90-4A2E-8931-9EF4C8105A9B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Stronati
@ast
Laura Stronati
@en
Laura Stronati
@es
Laura Stronati
@nl
Laura Stronati
@sl
type
label
Laura Stronati
@ast
Laura Stronati
@en
Laura Stronati
@es
Laura Stronati
@nl
Laura Stronati
@sl
prefLabel
Laura Stronati
@ast
Laura Stronati
@en
Laura Stronati
@es
Laura Stronati
@nl
Laura Stronati
@sl
P106
P1153
6508196503
P21
P31
P496
0000-0001-5222-9497